Product Images Doxazosin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Doxazosin NDC 50090-6401 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structure - image 1
image - image 2
The text describes the results of three studies evaluating the efficacy of doxazosin mesylate in treating benign prostatic hyperplasia (BPH). The studies measured changes in maximum flow rate and symptom score (measured using the AUA questionnaire or Modified Boyarsky Questionnaire) after titration to a fixed or maximum dose of doxazosin mesylate or placebo over a period of 12-14 weeks. The results show that doxazosin mesylate leads to improvements in maximum flow rate and symptom score compared to placebo, with statistically significant differences (p < 0.05) observed for some doses in some studies.*
1 - image 3
This text provides information about a clinical study that measured the mean change in total symptom scores and maximum urinary flow rate in patients receiving doxazosin titration or placebo treatment over a duration of several weeks. The graph shows a significant improvement in symptom scores in patients receiving doxazosin compared to placebo, and a significant increase in maximum urinary flow rate from baseline in patients receiving doxazosin. The study used a p-value of 0.05 to determine statistical significance.*
Label Image - lbl500906401
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.